IBM is a slowly progressive disease with no proven treatment to date, unfortunately. The goals of care are to delay decline and maintain remaining muscle strength. The cornerstone of treatment is physical/occupational therapy. Blood flow restriction seems to anecdotally help some patients, pending t...

I also follow Dr. @Eleni Tiniakou's approach to IBM management. Support groups such as The Myositis Association (TMA) are very beneficial for IBM patients and their families, given the progressive, insidious nature of this disease. It is extremely important patients be explicitly counseled about th...